PubRank

K L Dretchen

Author PubWeight™ 29.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cocaine detoxification by human plasma butyrylcholinesterase. Toxicol Appl Pharmacol 1997 1.49
2 Therapeutic use of butyrylcholinesterase for cocaine intoxication. Toxicol Appl Pharmacol 1997 1.16
3 Effect of electrical and chemical stimulation of the raphe obscurus on phrenic nerve activity in the cat. Brain Res 1986 1.02
4 Cyclic nucleotides and neuromuscular transmission. Fed Proc 1979 1.00
5 Hypotensive effect of urapidil: CNS site and relative contribution. J Cardiovasc Pharmacol 1987 0.97
6 Brainstem nicotinic receptor subtypes that influence intragastric and arterial blood pressures. J Pharmacol Exp Ther 2000 0.95
7 Sympathetic nervous system mediated cardiovascular effects of cocaine are primarily due to a peripheral site of action of the drug. Drug Alcohol Depend 1995 0.93
8 Evidence for 5-hydroxytryptamine, substance P, and thyrotropin-releasing hormone in neurons innervating the phrenic motor nucleus. J Neurosci 1984 0.93
9 Characterization of the train-of-four response in fast and slow muscles: effect of d-tubocurarine, pancuronium, and vecuronium. Anesthesiology 1983 0.92
10 Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla. J Pharmacol Exp Ther 1988 0.91
11 Malabsorption of pyridostigmine in patients with myasthenia gravis. Neurology 1977 0.89
12 Evidence for a prejunctional role of cyclic nucleotides in neuromuscular transmission. Nature 1976 0.88
13 Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration. Eur J Pharmacol 1996 0.85
14 The effect of neuromuscular blocking agents on acetylcholine release. Proc Soc Exp Biol Med 1971 0.84
15 Cyclic nucleotides in neuromuscular transmission. Anesth Analg 1981 0.84
16 Comparison of midazolam and diazepam by the intramuscular route for the control of seizures in a mouse model of status epilepticus. Epilepsia 1990 0.84
17 Miniature end plate potentials recorded from mammalian myoneural junction in vivo. Science 1974 0.83
18 A role of cyclic nucleotides in neuromuscular transmission. J Pharmacol Exp Ther 1976 0.83
19 Cocaine acts in the central nervous system to inhibit sympathetic neural activity. J Pharmacol Exp Ther 1991 0.82
20 Effect of various antibiotics on neuromuscular transmission. Eur J Pharmacol 1972 0.82
21 In-vitro investigation of a new neuromuscular relaxant, AH8165. Anesthesiology 1975 0.81
22 Azathioprine: effects on neuromuscular transmission. Anesthesiology 1976 0.81
23 Evidence for a cyclic nucleotide-mediated calcium flux in motor nerve terminals. Nature 1977 0.81
24 Dantrolene sodium: effects on smooth muscle. Eur J Pharmacol 1978 0.79
25 The effect of verapamil on the gastrocnemius and soleus muscles of the cat in vivo. Eur J Pharmacol 1979 0.78
26 Toxicities in rats with free versus liposomal encapsulated cisplatin. Am J Obstet Gynecol 1991 0.78
27 Effects of cyclic nucleotides on mammalian motor nerve terminals. J Pharmacol Exp Ther 1976 0.78
28 Effect of pancuronium bromide on acetylcholine release. Proc Soc Exp Biol Med 1972 0.78
29 Mechanisms of respiratory failure produced by neostigmine and diisopropyl fluorophosphate. Eur J Pharmacol 1991 0.77
30 Effects of furosemide on neural mechanisms in Aplysia. J Neurobiol 1981 0.77
31 Relative effects of streptomycin on motor nerve terminal and endplate. Eur J Pharmacol 1973 0.76
32 Approaches to protection against nerve agent poisoning. (Naphthylvinyl)pyridine derivatives as potential antidotes. J Med Chem 1988 0.76
33 Ketamine: myoneural activity and interaction with neuromuscular blocking agents. Eur J Pharmacol 1973 0.76
34 Beneficial effect of fluorocarbon emulsion media on the function of neuromuscular preparations in vitro. J Gen Physiol 1977 0.75
35 Protection by phenytoin and calcium channel blocking agents against the toxicity of diisopropylfluorophosphate. Toxicol Appl Pharmacol 1986 0.75
36 Intravenous NBQX inhibits spontaneously occurring sympathetic nerve activity and reduces blood pressure in cats. Eur J Pharmacol 1994 0.75
37 Effects of calcium on a cyclic nucleotide system in soleus motor nerve terminals. Eur J Pharmacol 1979 0.75
38 Cardiovascular effects of 1-methyl-4-(1-naphthylvinyl)piperidine hydrochloride. Eur J Pharmacol 1988 0.75
39 Effects of calcium channel blocking agents on neostigmine-induced fasciculations. Eur J Pharmacol 1989 0.75
40 A method of recording nerve terminal activity in the frog. J Appl Physiol 1973 0.75
41 Biphasic action of ethanol on contraction of skeletal muscle. Eur J Pharmacol 1975 0.75
42 The effects of gallamine on nerve terminals and endplates. Anesthesiology 1973 0.75
43 Role of the sympathetic nervous system in the cardiovascular effects of cocaine. NIDA Res Monogr 1991 0.75
44 Effects of phenytoin on the cyclic nucleotide system in the motor nerve terminal. Epilepsia 1977 0.75
45 Augmented anti-acetylcholine receptor response following long-term penicillamine administration. Ann Neurol 1984 0.75
46 Cocaine inhibits sympathetic neural activity by acting in the central nervous system and at the sympathetic ganglion. J Pharmacol Exp Ther 1996 0.75
47 Potentiation of MK-801-induced breathing impairment by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. Eur J Pharmacol 1994 0.75
48 Studies of the neuromuscular blocking effects of BW 403C65 in frog and cat muscle. Br J Anaesth 1975 0.75
49 Spinal cord contusion in the rat: somatosensory evoked potentials as a function of graded injury. J Neurotrauma 1988 0.75
50 Physostigmine inhibition of 3',5'-cyclic AMP phosphodiesterase from cat sciatic nerve. J Pharmacol Exp Ther 1984 0.75
51 Diphenylbarbituric acid: its effects on neuromuscular and spinal cord function in the cat. Epilepsia 1985 0.75
52 Changes in vascular reactivity and renal hemodynamics induced by benzyltrimethylammonium bromide (BTM). J Pharmacol Exp Ther 1972 0.75
53 An investigation of the effects of a pyridyl and a piperidyl 1, 3-dioxolane derivative on neuromuscular transmission. Arch Int Pharmacodyn Ther 1976 0.75
54 Kinetic parameters of 3',5'-cAMP phosphodiesterase in cat sciatic nerve. Biochem Pharmacol 1983 0.75
55 Effects of furosemide on the neuromuscular junction. Anesthesiology 1982 0.75
56 d-Tubocuraraine effects on nerve-terminal and neuromuscular conduction. Anesthesiology 1972 0.75
57 Quantal release in cut muscle: effects of limited calcium availability. Life Sci 1981 0.75
58 Inhibition of brain choline acetyltransferase in vivo: (E)-1-methyl-4-(1-naphthylvinyl)-1,2,3,6-tetrahydropyridine hydrochloride (B115), a depot form of a potent inhibitor. Toxicol Appl Pharmacol 1991 0.75
59 Acute effects of calcitonin gene-related peptide on the mechanical and electrical responses of the rat hemidiaphragm. J Pharmacol Exp Ther 1993 0.75
60 Neuroexcitatory and depressant effects of penicillin at the cat soleus neuromuscular junction. Epilepsia 1975 0.75
61 Absence of recurarization upon rewarming. Anesthesiology 1973 0.75
62 Carbamazepine suppression of post-tetanic potentiation at the neuromuscular junction. J Pharmacol Exp Ther 1978 0.75
63 Respiratory depression produced by intravenously administered NBQX. Pharmacology 1998 0.75
64 Actions of a new muscle relaxant (AH8165) on neuromuscular transmission. Anesthesiology 1975 0.75
65 Effect of anesthetics on acetylcholine release from the myoneural junction. Proc Soc Exp Biol Med 1972 0.75
66 Effects of pancuronium bromide on the motor nerve terminal. Eur J Pharmacol 1972 0.75